Induction of murine CD5 expression by v-H-ras

Immunology

Volumn 90, Issue 1, 1997, Pages 30-37

  Weichert, T R ^a   Schwartz, R C ^a,b  

^a Michigan State University ^*  (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BONE MARROW; GENE EXPRESSION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL;

EID: 0031014036     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1997.00133.x     Document Type: Article

References (35)

1. KIPPS T. (1989) The CD5 B cell. Adv Immunol 47, 117.
2. FREEMAN M., ASHKENAS J., REES D.J.G. et al. (1990) An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci USA 87, 8811.
3. fyn. Proc Natl Acad Sci USA 89, 9311.
4. OSMAN N., LEY S.C. & CRUMPTON M.J. (1992) Evidence for an association between the T cell receptor/CD-3 complex and the CD5 antigen in human T lymphocytes. Eur J Immunol 22, 2995.
5. LANKESTER A.C., VAN SCHIJNDEL G.M.W., CORDELL J.L., VAN NOESEL C.J.M. & VAN LIER A.W. (1994) CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol 24, 812.
6. VAN DE VELDE H., VON HOEGEN I., LUO W., PARNES J.R. & THIELEMANS K. (1991) The B-cell surface protein CD72/Lyb-2 is the ligand tor CD5. Nature 351, 662.
7. BRAUN J. (1983) Spontaneous in vitro occurrence and long-term culture of murine B lymphoblast cell lines. J Immunol 130, 2133.
8. + PRO-B lymphocyte clones. Phenotype, growth requirements and differentiation in vitro and in vivo. EMBO J 6, 3687.
9. WHITLOCK C.A. & WITTE O.N. (1982) Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc Natl Acad Sci USA 79, 3608.
10. SCHWARTZ, R.C., STANTON L.W., RILEY S.C., MARCU K.B. & WITTE O.N. (1986) Synergism of v-myc and v-Ha-ras in the in vitro neoplastic progression of murine lymphoid cells. Mol Cell Biol 6, 3221.
11. PIERCE J.H. & AARONSON S.A. (1982) BALB- and Harvey-murine sarcoma virus transformation of a novel lymphoid progenitor cell. J Exp Med 156, 873.
12. HOLMES K.L., PIERCE J.H., DAVIDSON W.F. & MORSE 3RD, H.C. (1986) Murine hematopoietic cells with pre-B or pre-B/myeloid characteristics are generated by in vitro transformation with retroviruses containing fes, ras, abl and src oncogenes. J Exp Med 164, 443.
13. KANTOR A.B. & HERZENBERG L.A. (1993) Origin of murine B cell lineages. Annu Rev Immunol 11, 501.
14. KANTOR A.B., STALI. A.M., ADAMS S., WATANABE K. & HERZENBERG L.A. (1995) De novo development and self-replenishment of B cells. Int Immunol 7, 55.
15. JYONOUCHI H., Voss R.M. & GOOD R.A. (1990) Up-regulation and down-regulation of cell surface and mRNA expression of CDS antigen by various humoral factors on murine 70Z/3 pre-B cell leukemia cell line: IL-4 down-regulates CD5 antigen expression. Cell Immunol 130, 66.
16. BROOKS K.H., YOL Y.S. & PESTKA J.J. (1992) CD5 expression is modulated as the B cell moves through the cell cycle. Ann NY Acad Sci 651, 259.
17. CONG Y.Z., RABIN E. & WORTIS H.H. (1991) Treatment of murine CD5-B cells with anti-Ig, but not LPS, induces surface CDS: two B-cell activation pathways. Intl Immunol 3, 467.
18. WHITLOCK C.A., ZIEGLER S.F., TREIMAN L.J., STAFFORD J.I. & WITTE O.N. (1983) Differentiation of cloned populations of immature B cells after transformation with Abelson murine leukemia virus. Cell 32, 903.
19. TRAVIS A., AMSTERDAM A., BELANGER C. & GROSSCHEDL R. (1991) LEF-1, a gene encoding a lymphoid-specific protein with an HMG domain, regulates T-cell receptor α enhancer function. Genes Dev 5, 880.
20. KIM K.J., KANELLOPOULOS-LANGEVIN C., MERWIN R.M., SACHS D.H. & ASOFSKY R. (1979) Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol 122, 549.
21. MANN R., MULLIGAN R.C. & BALTIMORE D. (1983) Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153.
22. CEPKO C.L., ROBERTS B.E. & MULLIGAN R.C. (1984) Construction and applications of a highly transmissible murine retrovirus shuttle vector. Cell 37, 1053.
23. GORMAN C.M., MOFFAT L.F. & HOWARD B.H. (1982) Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells. Mol Cell Biol 2, 1044.
24. SCHWARTZ R.C., SONENSHEIN G.E., BOTHWELL A. & GEFTER M.L. (1981) Multiple expression of Ig λ-chain encoding RNA species in murine plasmacytoma cells. J Immunol 126, 2104.
25. HUANG H.-J., JONES N.H., STROMINGER J.L. & HERZENBERG L.A. (1987) Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1 (CD5). Proc Natl Acad Sci USA 84, 204.
26. 2-microglobulin cDNA clones: a screening procedure for cDNA clones corresponding to rare mRNAs. Proc Nail Acad Sci USA 78, 2253.
27. LEDBETTER J.A. & HERZENBERG L.A. (1979) Xenogeneic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol Rev 47, 63.
28. WEICHERT T.R. & SCHWARTZ R.C. (1995) Cloning of the murine CD5 promoter and its tissue-specific regulation. J Immunol 154, 4603.
29. YAMAGUCHI Y., SATAKE M. & ITO Y. (1989) Two overlapping sequence motifs within the polyoma virus enhancer are independently the targets of stimulation by both the tumor promoter 12-O-tetradecanoylphorbol-13-acetate and the Ha-ras oncogene. J Virol 63, 1040.
30. MILLER R.A. & GRALOW J. (1984) The induction of Leu-1 antigen expression in human malignant and normal B cells by phorbol myristic acetate (PMA). J Immunol 133, 3408.
31. CARRERA A.C., CARDENAS L., TUGORES A., ALONSO M., SANCHEZMADRID F. & DE LANDAZURI M.O. (1989) Activators of protein kinase C up-regulate the cell surface expression of CD2 and CD5 T cell glycoproteins. J Biol Chem 264, 15650.
32. OWEN R.D. & OSTROWSKI M.C. (1990) Transcriptional activation of a conserved sequence elements by ras does not require c-fos or c-jun. Proc Natl Acad Sci USA 87, 3866.
33. REDDY M.A., LANGER S.J., COLMAN M.S. & OSTROWSKI M.C. (1992) An enhancer element responsive to ras and fins signalling pathways is composed of two distinct nuclear factor binding sites. Mol Endocrinol 6, 1051.
34. ENDO K., BORER C.H. & TSUJIMOTO Y. (1991) Modulation of LFA-1 surface antigen expression by activated H-ras oncogene in EBV-infected human B-lymphoblast cells. Oncogene 6, 1391.
35. GREAVES M.F., CHAN L.C., FURLEY A.J.W., WATT S.M. & MOLGARD H.W. (1986) Lineage promiscuity in hemapoietic differentiation and leukemia. Blood 67, 1.